Studies suggest that the incidence of coinfections in patients with the coronavirus disease
2019 (COVID-19) is low, but a large number of patients receive antimicrobials during …

The increased incidence of antimicrobial resistance during coronavirus disease 2019
(COVID-19) is a very important collateral damage of global concern. The cause is …

Background Current guidelines recommend empiric antibiotics be used only for severe
cases of coronavirus disease 2019 (COVID-19) or in cases where there is high clinical …

Background Antibiotics may be indicated in patients with COVID-19 due to suspected or
confirmed bacterial superinfection. Objectives To investigate antibiotic prescribing practices …

Objectives To characterise the factors, outcomes and infections associated with antibiotic
use in COVID-19 patients. Methods Records of patients with RT-PCR-confirmed COVID-19 …

Antimicrobial resistance (AMR) is a global concern, and antibiotic use has risen throughout
the COVID-19 pandemic. Up to 75% of COVID-19 patients are treated with antibiotics …

Hospitalized patients with SARS-CoV-2 infection (COVID-19) often receive antibiotics for
suspected bacterial coinfection. We estimated the incidence of bacterial coinfection and …

This scoping review provides new evidence on the prevalence and patterns of global
antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used …

Introduction Excessive use of antibiotics has been frequently reported in hospitalized
patients with COVID-19 worldwide, compared to the actual number of bacterial co-infections …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …